Punch & Associates Investment Management Inc. Has $4.95 Million Holdings in Viemed Healthcare, Inc. $VMD

Punch & Associates Investment Management Inc. reduced its position in shares of Viemed Healthcare, Inc. (NASDAQ:VMD) by 20.0% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 537,361 shares of the company’s stock after selling 133,999 shares during the period. Punch & Associates Investment Management Inc.’s holdings in Viemed Healthcare were worth $4,949,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also recently added to or reduced their stakes in VMD. State of Alaska Department of Revenue acquired a new stake in shares of Viemed Healthcare during the fourth quarter worth $25,000. Kemnay Advisory Services Inc. bought a new position in shares of Viemed Healthcare during the fourth quarter worth approximately $46,000. Quarry LP acquired a new stake in shares of Viemed Healthcare in the third quarter valued at approximately $48,000. AQR Capital Management LLC acquired a new stake in shares of Viemed Healthcare in the first quarter valued at approximately $90,000. Finally, SG Americas Securities LLC bought a new stake in shares of Viemed Healthcare in the fourth quarter valued at approximately $101,000. Institutional investors own 74.24% of the company’s stock.

Viemed Healthcare Stock Performance

Shares of Viemed Healthcare stock opened at $11.77 on Friday. The company has a 50 day moving average of $10.90 and a 200-day moving average of $9.49. The company has a current ratio of 1.22, a quick ratio of 1.10 and a debt-to-equity ratio of 0.06. Viemed Healthcare, Inc. has a 1-year low of $5.93 and a 1-year high of $12.61. The company has a market cap of $451.26 million, a PE ratio of 31.81 and a beta of 1.10.

Viemed Healthcare (NASDAQ:VMD) last issued its earnings results on Tuesday, May 5th. The company reported $0.06 earnings per share for the quarter, missing analysts’ consensus estimates of $0.09 by ($0.03). Viemed Healthcare had a net margin of 5.20% and a return on equity of 10.52%. The business had revenue of $75.41 million during the quarter, compared to analyst estimates of $74.40 million. As a group, equities research analysts forecast that Viemed Healthcare, Inc. will post 0.44 earnings per share for the current fiscal year.

Analyst Ratings Changes

Separately, Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Viemed Healthcare in a report on Friday, July 17th. Two equities research analysts have rated the stock with a Hold rating, According to MarketBeat.com, the stock presently has a consensus rating of “Hold”.

Insider Transactions at Viemed Healthcare

In related news, insider William Frazier sold 10,000 shares of the company’s stock in a transaction that occurred on Thursday, June 25th. The shares were sold at an average price of $11.72, for a total transaction of $117,200.00. Following the completion of the transaction, the insider directly owned 73,214 shares in the company, valued at $858,068.08. This represents a 12.02% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Timothy Smokoff sold 20,000 shares of the stock in a transaction that occurred on Wednesday, June 24th. The shares were sold at an average price of $11.50, for a total transaction of $230,000.00. Following the completion of the transaction, the director directly owned 75,518 shares of the company’s stock, valued at approximately $868,457. The trade was a 20.94% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders own 20.60% of the company’s stock.

Viemed Healthcare Profile

Viemed Healthcare, Inc (NASDAQ: VMD) is a provider of home-based respiratory therapy services, specializing in the management of patients requiring long-term mechanical ventilation and pulmonary support. The company’s offerings encompass invasive and noninvasive ventilation, airway clearance therapies, cough assist devices, and supplemental oxygen. Viemed combines durable medical equipment with clinical care, delivering tailored respiratory treatment plans that are overseen by licensed respiratory therapists and registered nurses.

Founded in the early 2010s and headquartered in Birmingham, Alabama, Viemed has grown its footprint to serve patients across multiple states in the United States.